As per the research report, the size of the Asia Pacific PEGylated Proteins Market is valued at USD 150.17 million in 2020 and estimated to be growing at a CAGR of 12.50%, to reach USD 270.6 million by 2025. The market is showing great potential in the forecast period, i.e. till 2020-2025.
PEGylation is a process of attachment of covalent or non-covalent bond of PolyEthylene Glucol (PEG) polymer chains to molecules and macrostructures, like protein in case of PEGylation of proteins. PEGylated Protein has become very important because the PEGylation of proteins helps to protect protein against enzymatic dehydration and it also increases the half-life of drugs.
Increasing R and D investments on pharmaceuticals and healthcare sector in this region because of increasing awareness of people regarding health-related issues due to government campaigns, the higher population in this region, high risk of diseases, increase in adoption of protein-based drugs over non-protein based drugs and increased half-life of drugs due to PEGylation are the major driving factors of this market. On the other hand, the unpredictable accumulation of high molecular weight compounds in liver might lead to inclusion bodies with no known consequences. Furthermore, the chain length of these compounds can change which might lead to unexpected clearance times in vivo. These concerning matters are challenging this market.
This research report segmented and sub-segmented into the following categories:
Geographically, this market has been sub-categorized into India, China, Japan, South Korea, and Australia. Asia-Pacific is the fastest-growing region among all the segments mentioned in the global report for this market. India and China are leading the way in this market in terms of market share whereas in terms of technological advances, Japan is ahead of other countries in this region.
The Top companies leading in the APAC PEGylated Proteins Market profiled in the report are Laysan Bio, Ltd., Iris Biotech GmbH, Biomatrik Inc., Quanta BioDesign Ltd., Cealares GmbH, Creative PEGworks, Jenkem Technology USA Inc., NOF Corporation, Thermo Fisher Scientific Inc., and Merck Millipore.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Protein Type
5.1.1 Introduction
5.1.2 Interferons
5.1.3 Erythropoietin
5.1.4 mAbs
5.1.5 Y-o-Y Growth Analysis, By Protein Type
5.1.6 Market Attractiveness Analysis, By Protein Type
5.1.7 Market Share Analysis, By Protein Type
5.2 Consumables
5.2.1 Introduction
5.2.2 Reagents
5.2.3 PEGylation Kits
5.2.4 Y-o-Y Growth Analysis, By Consumables
5.2.5 Market Attractiveness Analysis, By Consumables
5.2.6 Market Share Analysis, By Consumables
5.3 Application
5.3.1 Introduction
5.3.2 Chronic Kidney Diseases
5.3.3 Cancer Treatment
5.3.4 Y-o-Y Growth Analysis, By Application
5.3.5 Market Attractiveness Analysis, By Application
5.3.6 Market Share Analysis, By Application
5.4 End-Users
5.4.1 Introduction
5.4.2 Pharmaceuticals & Biotechnology Companies
5.4.3 CROs
5.4.4 Academic Research Institutes
5.4.5 Y-o-Y Growth Analysis, By End-Users
5.4.6 Market Attractiveness Analysis, By End-Users
5.4.7 Market Share Analysis, By End-Users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Protein Type
6.1.3.3 By Consumables
6.1.3.4 By Application
6.1.3.5 By End-Users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Protein Type
6.1.4.3 By Consumables
6.1.4.4 By Application
6.1.4.5 By End-Users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Protein Type
6.1.5.3 By Consumables
6.1.5.4 By Application
6.1.5.5 By End-Users
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Laysan Bio Ltd.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Iris Biotech GmbH
8.3 Biomatrik Inc.
8.4 Quanta BioDesign Ltd.
8.5 Cealares GmbH
8.6 Creative PEGworks
8.7 Jenkem Technology USA Inc.
8.8 NOF Corporation
8.9 Thermo Fisher Scientific Inc.
8.10 Merck Millipore
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
